← Open Payments lookup

CORA RIDENOUR: Open Payments

NPI 1750168076 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$5,148 in 269 payments from 20 companies in 2025. Trend: 2023 $393 · 2024 $4,234 · 2025 $5,148

Food & beverage: $5,056Education: $92
CompanyPaymentsAmount
ABBVIE INC.53$1,246
Salix Pharmaceuticals, a division of Bausch Health US, LLC96$1,193
Janssen Biotech, Inc.21$548
Ardelyx, Inc.17$338
QOL Medical, LLC12$310
Takeda Pharmaceuticals U.S.A., Inc.18$286
Alnylam Pharmaceuticals Inc.3$178
Regeneron Healthcare Solutions, Inc.8$169
PFIZER INC.13$158
GENZYME CORPORATION4$123

Products named: XIFAXAN, RINVOQ, TREMFYA, IBSRELA, SKYRIZI, Sucraid, DUPIXENT, ENTYVIO.

Industry payments across CA — which companies pay providers there.